BDTX - Black Diamond Therapeutics to Participate in Upcoming Investor Conferences | Benzinga
CAMBRIDGE, Mass. and NEW YORK, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (NASDAQ:BDTX), a clinical-stage precision oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with genetically defined cancers, today announced that company management will participate in three upcoming investor conferences:
- The 2023 Wells Fargo Healthcare Conference on Wednesday, September 6, 2023, in Boston, MA.
- The Morgan Stanley 21st Annual Global Healthcare Conference on Monday, September 11, 2023. Black Diamond President and Chief Executive Officer, David M. Epstein, Ph.D. will participate in a fireside chat at 3:35 p.m. ET in New York, ...